Drug News
-
A TikTok Mother’s Journey: Overcoming Mitchell Syndrome with the Wahls Protocol
In a world where challenges seem insurmountable, there are stories that inspire hope and perseverance. One such story is that…
Read More » -
Medical Billing Outsourcing Market Projected to Reach USD 40.1 Billion by 2032 – DataHorizzon Research
The global medical billing outsourcing market is poised for remarkable growth, with projections indicating a surge to USD 40.1 billion…
Read More » -
Global Biologic Therapeutics Market Set to Grow by USD 286.12 Billion by 2027, Boosted by Biosimilar Introductions: Technavio
According to the latest analysis by Technavio, the global biologic therapeutics market is anticipated to witness substantial expansion, projecting a…
Read More » -
NRx Pharmaceuticals Unveils pH-Neutral IV Ketamine Formulation, HTX-100, Revolutionizing Treatment
NRx Pharmaceuticals, Inc. has made a groundbreaking announcement regarding the development of a new, proprietary formulation of intravenous (IV) ketamine,…
Read More » -
Why Amylyx Removed Relyvrio From the U.S. and Canadian Markets
The decision by Amylyx Pharmaceuticals to remove its ALS drug, Relyvrio, from the U.S. and Canadian markets stems primarily from…
Read More » -
Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028
The global market for induced pluripotent stem cells (iPSCs) is poised for significant growth, according to the latest research study…
Read More » -
Debate Arises Over Safety of Benzoyl Peroxide in Acne Products Following High Benzene Levels Discovery
An independent laboratory’s petition to recall acne treatment products containing benzoyl peroxide (BP) due to high levels of the carcinogen…
Read More » -
Novo Nordisk Parent Resubmits Catalent Deal Application to FTC
Novo Nordisk’s parent company, Novo Nordisk Foundation, has refiled its application to the U.S. Federal Trade Commission (FTC) seeking approval…
Read More » -
Appeals Court Upholds Dismissal: Parents’ Claims Over Abbott Formula Price Dismissed
The 7th U.S. Circuit Court of Appeals has affirmed the dismissal of a proposed class action lawsuit brought by parents…
Read More » -
FDA Greenlights Vanda Pharmaceuticals’ Bipolar Disorder Drug: Fanapt Approved for Manic Episodes
Vanda Pharmaceuticals Inc. celebrated a significant milestone as the U.S. Food and Drug Administration (FDA) granted approval for its groundbreaking…
Read More »